New York Joins Multistate Lawsuit Against Trump Administration Over CDC Funding Cuts

<>

The legal action targets an illegal plan by the U.S. Department of Health and Human Services (HHS) to cut over $600 million in Centers for Disease Control and Prevention (CDC) grants exclusively across four Democratic-led states: California, Colorado, Illinois, and Minnesota, threatening critical public health infrastructure and disease treatment funding.

The Fiscal Anatomy of the Public Health Infrastructure Block Grant Threat

Among the affected jurisdictions, California faces the largest proportional deficit. The state’s public health apparatus relies heavily on the Public Health Infrastructure Block Grant (PHIG) program to maintain workforce readiness, laboratory capacity, and disease surveillance systems. In California alone, the disputed PHIG funding totals $180 million, with approximately $130 million remaining unspent and actively obligated for ongoing community health programs.

Legal Arguments and the Administrative Procedure Act Threshold

Filed in the U.S. District Court for the Northern District of Illinois, the multi-state complaint asserts that the proposed funding terminations violate foundational federal administrative statutes. The plaintiff states argue that the sudden cuts breach the Administrative Procedure Act’s strict requirement for reasoned decision-making. Furthermore, the lawsuit contends that federal agencies exceeded their statutory authority by attempting to impose retroactive conditions on previously awarded federal funds.

“President Trump is resorting to a familiar playbook. He is using federal funding to compel states and jurisdictions to follow his agenda. Those efforts have all previously failed, and we expect that to happen once again,” stated California Attorney General Rob Bonta in the official press announcement. Alongside the complaint, the coalition filed a motion for a temporary restraining order to block the implementation of the funding cuts before fiscal disbursements are halted.

Market Implications and Operational Risk Management for Fiscal Q3 and Q4

>